Search results
Results from the Health.Zone Content Network
1907: Alembic Pharmaceuticals, one of the oldest pharmaceutical companies in India, was established in Vadodara, Gujarat.This was just six years after India's first domestic pharmaceutical unit, Bengal Chemical and Pharmaceutical Works, was set up in Calcutta.
In 2010, Sun Pharmaceuticals of India acquired a majority stake in the company. [6] On 22 March 2012, the company's shares were re-listed on the NYSE. In 2013, Sun Pharmaceuticals attempted to buy the remaining shares in the company (it owns 69% stake), but as the company's financial performance improved, shareholders rejected the offer and the company remained publicly listed.
Bausch Health Companies Inc. (formerly Valeant Pharmaceuticals International, Inc.) is an American-Canadian multinational specialty pharmaceutical company based in Laval, Quebec, Canada. It develops, manufactures and markets pharmaceutical products and branded generic drugs , primarily for skin diseases , gastrointestinal disorders , eye health ...
Acorda Therapeutics, Inc. is an American biotechnology company based in Pearl River, New York.The company develops therapies that improve neurological function in people with Parkinson's disease, multiple sclerosis and other neurological disorders.
Vyera Pharmaceuticals (formerly Turing Pharmaceuticals) is a pharmaceutical company incorporated in Zug, Switzerland, with offices in New York City. The company started to do business in the US as Vyera Pharmaceuticals in September 2017.
Latest Health News FDA OKs First Treatment for Rare, Deadly Genetic Disorder Miplyffa treats Niemann-Pick disease type C, which progressively impacts the abilities to speak, swallow, and walk or ...
Acuitas Therapeutics Inc. is a Canadian biotechnology company based in Vancouver, British Columbia.The company was established in February 2009 to specialize in the development of delivery systems for nucleic acid therapeutics based on lipid nanoparticle (LNP) technology, a key component of the mRNA vaccines deployed for COVID-19.
On 1 October 2013, Gildemeister Aktiengesellschaft became DMG Mori Seiki Aktiengesellschaft. Mori Seiki changed its name to DMG Mori Seiki Company Limited. On the global market, both companies used the DMG MORI brand. On 21 January 2015, the DMG Mori Seiki Aktiengesellschaft signed another cooperation agreement with DMG Mori Seiki Co., Ltd.